Tag Archives: Kyle Rose

Analysts Offer Insights on Healthcare Companies: Alphatec Holdings (NASDAQ: ATEC), Ocuphire Pharma (NASDAQ: OCUP) and Ontrak (NASDAQ: OTRK)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Alphatec Holdings (ATEC – Research Report), Ocuphire Pharma (OCUP – Research Report) and Ontrak (OTRK – Research Report) with bullish sentiments. Ocuphire

Bioventus (BVS) Received its Third Buy in a Row

After Goldman Sachs and Morgan Stanley gave Bioventus (NASDAQ: BVS) a Buy rating last month, the company received another Buy, this time from Canaccord Genuity. Analyst Kyle Rose maintained a Buy rating on Bioventus today and set a price target

TELA Bio (TELA) Gets a Buy Rating from Canaccord Genuity

In a report released yesterday, Kyle Rose from Canaccord Genuity maintained a Buy rating on TELA Bio (TELA – Research Report), with a price target of $18.00. The company’s shares closed last Wednesday at $14.00. According to TipRanks.com, Rose is

Canaccord Genuity Maintains Their Hold Rating on REPRO-MED Systems (KRMD)

In a report released yesterday, Kyle Rose from Canaccord Genuity maintained a Hold rating on REPRO-MED Systems (KRMD – Research Report), with a price target of $5.00. The company’s shares closed last Tuesday at $3.75, close to its 52-week low

SeaSpine Holdings (SPNE) Receives a Buy from Canaccord Genuity

In a report released today, Kyle Rose from Canaccord Genuity maintained a Buy rating on SeaSpine Holdings (SPNE – Research Report), with a price target of $25.00. The company’s shares closed last Monday at $18.34. According to TipRanks.com, Rose is

Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (NYSE: ZBH), Bluebird Bio (NASDAQ: BLUE) and Cortexyme (NASDAQ: CRTX)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zimmer Biomet Holdings (ZBH – Research Report), Bluebird Bio (BLUE – Research Report) and Cortexyme (CRTX – Research Report) with bullish sentiments.